Posted by Michael Wonder on 24 Sep 2019
Canadian Health Policy Institute reports national pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers: evidence counters Hoskins report
24 September 2019 - Constructive public discussion about a national pharmacare program in Canada is hindered by a lack of balance in the reporting of evidence.
Several studies have been published in the journal Canadian Health Policy, that offer an evidence-based perspective that counters the federal Hoskins report. The research shows that national pharmacare is unnecessary, bad for privately insured people and costly for taxpayers.
The research also recommends a less disruptive, less expensive policy option to close the real drug coverage gap caused by public formulary exclusions.
